首页> 外文期刊>Journal of minimally invasive gynecology >Laparoscopic supracervical hysterectomy with transcervical morcellation and sacrocervicopexy: initial experience with a novel surgical approach to uterovaginal prolapse.
【24h】

Laparoscopic supracervical hysterectomy with transcervical morcellation and sacrocervicopexy: initial experience with a novel surgical approach to uterovaginal prolapse.

机译:腹腔镜子宫上子宫切除术并经宫颈粉碎术和vic腔切除术:一种新颖的子宫脱垂手术方法的初步经验。

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this retrospective study was to evaluate the feasibility, safety, and efficacy of a new laparoscopic technique for the treatment of uterovaginal prolapse using a transcervical access port to minimize the laparoscopic incision. From February 2008 through August 2010, symptomatic pelvic organ prolapse in 43 patients was evaluated and surgically treated using this novel procedure. Preoperative assessment included pelvic examination, the pelvic organ prolapse quantification scoring system (POP-Q), and complex urodynamic testing with prolapse reduction to evaluate for symptomatic or occult stress urinary incontinence. The surgical procedure consisted of laparoscopic supracervical hysterectomy with transcervical morcellation and laparoscopic sacrocervicopexy with anterior and posterior mesh extension. Concomitant procedures were performed as indicated. All procedures were completed laparoscopically using only 5-mm abdominal port sites, with no intraoperative complications. Patients were followed up postoperatively for pelvic examination and POP-Q at 6 weeks, 6 months, and 12 months. The median (interquartile range) preoperative POP-Q values for point Aa was 0 (-1.0 to 1.0), and for point C was -1.0 (-3.0 to 2.0). Postoperatively, median points Aa and C were significantly improved at 6 weeks, 6 months, and 12 months (all p < .001). One patient was found to have a mesh/suture exposure from the sacrocervicopexy, which was managed conservatively without surgery. We conclude that laparoscopic supracervical hysterectomy with transcervical morcellation and laparoscopic sacrocervicopexy is a safe and feasible surgical approach to treatment of uterovaginal prolapse, with excellent anatomic results at 6 weeks, 6 months, and 12 months. Potential advantages of the procedure include minimizing laparoscopic port site size, decreasing the rate of mesh exposure compared with other published data, and reducing the rate of postoperative cyclic bleeding in premenopausal women by removing the cervical core. Longer follow-up is needed to determine the durability and potential long-term sequelae of the procedure.
机译:这项回顾性研究的目的是评估一种新的腹腔镜技术的可行性,安全性和有效性,该技术使用经子宫颈入路以最小化腹腔镜切口来治疗子宫阴道脱垂。从2008年2月到2010年8月,对43例有症状的盆腔器官脱垂进行了评估,并使用这种新方法进行了手术治疗。术前评估包括骨盆检查,骨盆器官脱垂量化评分系统(POP-Q)和复杂的尿动力学检查,并伴有脱垂,以评估症状性或隐性应激性尿失禁。外科手术包括腹腔镜经阴道子宫上子宫切除术和腹腔镜sa行腹膜前路和后路网状扩张术。如所示进行伴随的程序。所有手术仅在腹腔镜下5 mm腹腔部位完成,无术中并发症。术后6周,6个月和12个月对患者进行骨盆检查和POP-Q随访。 Aa点的术前POP-Q中值(四分位数范围)为0(-1.0至1.0),C点为-1.0(-3.0至2.0)。术后6周,6个月和12个月,中位点Aa和C显着改善(所有p <0.001)。发现一名患者的cro骨网状/缝线暴露,未经手术保守处理。我们得出的结论是,腹腔镜子宫上子宫切除术配合经阴道切开术和腹腔镜cro行子宫切除术是治疗子宫阴道脱垂的一种安全可行的手术方法,在6周,6个月和12个月时具有出色的解剖学效果。该方法的潜在优势包括最小化腹腔镜端口部位的大小,与其他已发表的数据相比降低网状暴露的速率以及通过移除颈椎核心来减少绝经前女性术后循环出血的速率。需要更长的随访时间来确定手术的持久性和可能的​​长期后遗症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号